Researchers from the Institute of Process Engineering (IPE) of the Chinese Academy of Sciences, in cooperation with Shenzhen Second People's Hospital, have developed a novel exosome-based therapeutic agent for treating traumatic CNS injuries. This treatment can alleviate neuronal apoptosis, restore glial homeostasis, and remodel glia-neuron networks, offering potent therapeutic benefits in murine (mouse) TBI and SCI models.